BioArctic Management

Management criteria checks 3/4

BioArctic's CEO is Gunilla Osswald, appointed in Jan 2014, has a tenure of 10.75 years. total yearly compensation is SEK22.38M, comprised of 19.8% salary and 80.2% bonuses, including company stock and options. directly owns 0.11% of the company’s shares, worth $1.43M. The average tenure of the management team and the board of directors is 5.8 years and 6.8 years respectively.

Key information

Gunilla Osswald

Chief executive officer

SEK 22.4m

Total compensation

CEO salary percentage19.8%
CEO tenure10.8yrs
CEO ownership0.1%
Management average tenure5.8yrs
Board average tenure6.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Gunilla Osswald's remuneration changed compared to BioArctic's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-SEK 88m

Mar 31 2024n/an/a

-SEK 122m

Dec 31 2023SEK 22mSEK 4m

SEK 229m

Sep 30 2023n/an/a

SEK 259m

Jun 30 2023n/an/a

SEK 270m

Mar 31 2023n/an/a

SEK 327m

Dec 31 2022SEK 9mSEK 5m

-SEK 11m

Sep 30 2022n/an/a

SEK 28m

Jun 30 2022n/an/a

-SEK 147m

Mar 31 2022n/an/a

-SEK 135m

Dec 31 2021SEK 5mSEK 3m

-SEK 120m

Sep 30 2021n/an/a

-SEK 114m

Jun 30 2021n/an/a

-SEK 97m

Mar 31 2021n/an/a

-SEK 101m

Dec 31 2020SEK 5mSEK 3m

-SEK 69m

Sep 30 2020n/an/a

-SEK 72m

Jun 30 2020n/an/a

-SEK 60m

Mar 31 2020n/an/a

SEK 78m

Dec 31 2019SEK 7mSEK 3m

SEK 88m

Sep 30 2019n/an/a

SEK 441m

Jun 30 2019n/an/a

SEK 475m

Mar 31 2019n/an/a

SEK 380m

Dec 31 2018SEK 5mSEK 3m

SEK 382m

Sep 30 2018n/an/a

SEK 58m

Jun 30 2018n/an/a

SEK 32m

Mar 31 2018n/an/a

SEK 29m

Dec 31 2017SEK 3mSEK 2m

SEK 15m

Compensation vs Market: Gunilla's total compensation ($USD2.13M) is below average for companies of similar size in the US market ($USD5.54M).

Compensation vs Earnings: Gunilla's compensation has increased whilst the company is unprofitable.


CEO

Gunilla Osswald (63 yo)

10.8yrs

Tenure

SEK 22,378,000

Compensation

Dr. Gunilla Osswald, PhD has been the Chief Executive Officer and President of BioArctic AB (publ) since 2014. Dr. Osswald has been a Director of Egetis Therapeutics AB (publ) (formerly known as PledPharma...


Leadership Team

NamePositionTenureCompensationOwnership
Gunilla Osswald
President & CEO10.8yrsSEK 22.38m0.11%
$ 1.4m
Pär Gellerfors
Co-Founder21.8yrsSEK 390.00kno data
Lars Lannfelt
Co-Founder21.8yrsSEK 2.54m33.41%
$ 447.0m
Anders Martin-Lof
Chief Financial Officer1.4yrsno datano data
Johanna Fälting
Chief Research Officer & Head of Researchno datano data0.051%
$ 679.1k
Christer Möller
VP of Pre-Clinical Development & Chief Scientific Officer18.8yrsno data0.063%
$ 844.3k
Oskar Bosson
VP and Head of IR & Communication4.4yrsno data0.016%
$ 216.5k
Leif Gallo
General Counsel and Head of Legal & IPno datano datano data
Harald Borgeke
Head of Public Affairs2.5yrsno datano data
Frida Lekander
Head of Marketing2.7yrsno datano data
Gunilla Andersson
Vice President of Human Resources5.8yrsno datano data
Mikael Moge
VP & Head of CMCno datano data0.011%
$ 141.1k

5.8yrs

Average Tenure

63yo

Average Age

Experienced Management: BRCT.F's management team is seasoned and experienced (5.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Pär Gellerfors
Co-Founder21.8yrsSEK 390.00kno data
Lars Lannfelt
Co-Founder21.8yrsSEK 2.54m33.41%
$ 447.0m
Eugen Steiner
Independent Chairman7.1yrsSEK 621.00k0.10%
$ 1.3m
Hans Wigzell
Member of Scientific Advisory Boardno datano datano data
Konrad Beyreuther
Member of the Scientific Boardno datano datano data
Marie Edström
Independent Director1.3yrsSEK 187.00kno data
Mikael Smedeby
Independent Director6.4yrsSEK 316.00k0.032%
$ 432.0k
Charlotta Ljungqvist
Independent Director3.4yrsSEK 318.00k0.0036%
$ 47.8k
Martin Ingelsson
Member of Scientific Boardno datano datano data
Staffan Pauli
Member of Scientific Advisory Boardno datano datano data
Ken Marek
Member of Scientific Advisory Boardno datano datano data
Kaj Blennow
Member of Scientific Advisory Boardno datano datano data

6.8yrs

Average Tenure

70yo

Average Age

Experienced Board: BRCT.F's board of directors are considered experienced (6.8 years average tenure).